Literature DB >> 2015890

The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis.

L Christmanson1, C Betsholtz, A Gustavsson, B Johansson, K Sletten, P Westermark.   

Abstract

A variety of mutations leading to amino acid substitutions have been described in the transthyretin gene in association with different familial amyloidoses and have been implicated to be involved in the pathogenesis of amyloid deposits. However, there has been disagreement whether or not a transthyretin mutation is present in the most common form of transthyretin-derived amyloid, namely senile systemic amyloidosis. Therefore, the cDNA sequence of liver transthyretin was determined in a 91-year-old patient with typical senile systemic amyloidosis. This sequence was completely normal and lacked any variation. We conclude that in senile systemic amyloidosis factors other than the presence of a sequentially variant transthyretin must determine the amyloid fibril formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015890     DOI: 10.1016/0014-5793(91)80387-i

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis.

Authors:  D E Jenne; K Denzel; P Blätzinger; P Winter; B Obermaier; R P Linke; K Altland
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 2.  The age related amyloids: a growing family of unique biochemical substances.

Authors:  G G Cornwell; K H Johnson; P Westermark
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

3.  Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations.

Authors:  A Gustavsson; U Engström; P Westermark
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

4.  Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.

Authors:  C D Link
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

5.  Structure of Met30 variant of transthyretin and its amyloidogenic implications.

Authors:  C J Terry; A M Damas; P Oliveira; M J Saraiva; I L Alves; P P Costa; P M Matias; Y Sakaki; C C Blake
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.